Therapeutic and cosmetic uses of botulinum neurotoxin serotype E
AssigneeIpsen Biopharm Ltd.
InventorLaurent Pons
Life of this patent
Estimating the term…
Abstract
A botulinum neurotoxin serotype E (BoNT/E) for use in treating a disorder or a cosmetic condition, wherein the BoNT/E provides a maximum inhibition of neurotransmitter secretion from a target cell or tissue 13 days or less after administration to a human subject and the inhibition is reduced but is greater than 25% at day 14 following administration. A method for treating a disorder or a cosmetic condition, the method comprising administering the aforementioned BoNT/E.
Claims24
A method for treating skin wrinkles in a subject in need thereof, the method comprising administering to the subject a total dose of BoNT/E of from about 0.03 ng to about 0.5 ng, wherein the BoNT/E is in a non-complexed form.
Dependencies are inferred from the claim text.